Literature DB >> 2644484

Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins.

O Skalli1, W Schürch, T Seemayer, R Lagacé, D Montandon, B Pittet, G Gabbiani.   

Abstract

We examined by immunofluorescence the distribution of vimentin, desmin, alpha-smooth muscle actin and alpha-sarcomeric actin in normal human soft tissues and in pathologic tissues containing myofibroblasts, including normally healing granulation tissue, hypertrophic scar, and fibromatosis. The pattern of actin isoforms was also documented biochemically by two-dimensional gel electrophoresis. Fibroblastic and/or myofibroblastic cells in each setting always expressed vimentin and never alpha-sarcomeric actin. Moreover, these cells showed an heterogeneous cytoskeletal composition which defined four phenotypes: (a) cells expressing only vimentin; (b) cells expressing vimentin, alpha-smooth muscle actin and desmin; (c) cells expressing vimentin and alpha-smooth muscle actin; and (d) cells expressing vimentin and desmin. Given this, two groups of lesions are distinguished: the first contains only vimentin cells and consists of normally healing granulation tissue, eschars and normally healed scars; the second contains vimentin cells admixed with variable proportions of vimentin, alpha-smooth muscle actin and desmin, vimentin and alpha-smooth muscle actin, and vimentin and desmin cells and consists of hypertrophic scars and fibromatoses. Immunogold electron microscopy showed that alpha-smooth muscle actin was present in a proportion of cells with ultrastructural features of myofibroblasts. Our findings suggest that contrary to myofibroblasts of normally healing granulation tissue and normally healed scars, myofibroblasts of pathologic conditions characterized by chronic retraction express always immunochemical features indicative of smooth muscle differentiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2644484

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  96 in total

1.  Proliferative retinal diseases: myofibroblasts cause chronic vitreoretinal traction.

Authors:  R Walshe; P Esser; P Wiedemann; K Heimann
Journal:  Br J Ophthalmol       Date:  1992-09       Impact factor: 4.638

2.  The myofibroblast markers α-SM actin and β-actin are differentially expressed in 2 and 3-D culture models of fibrotic and normal skin.

Authors:  M C Vozenin; J L Lefaix; R Ridi; D S Biard; F Daburon; M Martin
Journal:  Cytotechnology       Date:  1998-01       Impact factor: 2.058

Review 3.  Re-evaluation of fibroblasts and fibroblast-like cells.

Authors:  T Komuro
Journal:  Anat Embryol (Berl)       Date:  1990

4.  Inflammatory pseudotumor of lymph nodes. Immunohistochemical evidence for its fibrohistiocytic nature.

Authors:  F Facchetti; C De Wolf Peeters; I De Wever; G Frizzera
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

5.  The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis.

Authors:  C Kuhn; J A McDonald
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

6.  Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers.

Authors:  A Schmitt-Gräff; S Krüger; F Bochard; G Gabbiani; H Denk
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

7.  The deletion of transforming growth factor-beta-induced myofibroblasts depends on growth conditions and actin organization.

Authors:  P D Arora; C A McCulloch
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

8.  [Leiomyosarcoma of the inferior vena cava. Review of a rare disease].

Authors:  A M Müller; A M Chromik; B Bolik; K-M Müller; U Mittelkötter
Journal:  Pathologe       Date:  2005-03       Impact factor: 1.011

9.  Characterisation of myofibroblasts in fibrovascular tissues of primary and recurrent pterygia.

Authors:  A Touhami; M A Di Pascuale; T Kawatika; M Del Valle; R H Rosa; S Dubovy; S C G Tseng
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

10.  Resident mesenchymal cells and fibrosis.

Authors:  Nicol Hutchison; Cécile Fligny; Jeremy S Duffield
Journal:  Biochim Biophys Acta       Date:  2012-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.